Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin

To see complete record on, please visit this link

Id: NCT05467761

Organisation Name: University of Wisconsin, Madison

Overal Status: Not yet recruiting

Start Date: January 2023

Last Update: October 25, 2022

Lead Sponsor: University of Wisconsin, Madison

Brief Summary: The purpose of this research study is to compare an oral dose of psilocybin and an intravenous (IV) infusion of psilocybin to assess differences in how the drug is absorbed by the body, the psychedelic experience, and any side effects when taken by healthy adult participants. Participants can expect to be in the study for approximately 12 weeks.

  • Healthy

Total execution time in seconds: 0.58792304992676